VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare
VistaGen Therapeutics Inc. annual/quarterly long term debt history from 2016 to 2016. Long term debt refers to financial obligations that are due more than one year in the future.
- VistaGen Therapeutics Inc. long term debt for the quarter ending March 31, 2016 were 58,800.
- VistaGen Therapeutics Inc. long term debt for 2016 were 58,800.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| VistaGen Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2016 | $0 |
| VistaGen Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2016-03-31 | $0 |
VistaGen Therapeutics Inc. Long Term Debt — FAQ
VistaGen Therapeutics Inc. (VTGN) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VTGN's long term debt history?
The chart and table above show VistaGen Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.